Compare HCA Health Inc (HCA) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs CarMax, Inc — how do they compare? HCA Health Inc trades at $448.62 (market cap $96.35B), while CarMax, Inc trades at $52.91 (market cap $7.64B). The key difference: HCA Health Inc is far larger — about 12.6× CarMax, Inc's market cap, and HCA Health Inc pays a 0.7% dividend while CarMax, Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and CarMax, Inc for 49 Days on average.
| HCA | KMX | |
|---|---|---|
Market Cap | $96.35B | $7.64B |
Volume | 1,079,453 | 3,610,116 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $64.22 |
52-Week Low | $361.32 | $30.88 |
Typical Hold Time | 76 Days | 49 Days |
Enterprise Value | $146.88B | $25.34B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
CarMax (KMX) trades at $53.28, down 3.64% amid bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong revenue growth (Q2 2026 revenue up 19.5% to $7.9B) but thin net margins (1.06%). Analyst consensus leans cautious with 62% hold ratings, though price targets suggest 10.5% upside to $58.89. Recent leadership appointments and strategic updates signal management's focus on growth execution.
Outlook hinges on CarMax's ability to sustain unit sales momentum while improving profitability. The stock offers value appeal (P/S 0.28) but faces execution risks from high debt ($18.1B long-term) and competitive pressures. Near-term catalysts include November's strategic webcast and Q3 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
